Double-Blind Trial of Everolimus for Improving Social Abilities in PTEN Germline Mutations

Clinical trial NCT07218575 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07218575
Sponsor: Boston Children's Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Cowden's Disease Cowden's Syndrome Lhermitte-Duclos Disease Cerebellum Dysplastic Gangliocytoma Bannayan Zonana Syndrome Myhre Riley Smith Syndrome Riley Smith Syndrome PTEN Hamartoma Tumor Syndrome Bannayan Riley Ruvalcaba Syndrome

Start date: 2026-09-01
Primary completion: 2030-09-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.